Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cassava Sciences Inc (FLNA) vs Peloton Interactive Inc (PTON) Price & Performance

Cassava Sciences IncTrade
Peloton Interactive IncTrade

Price performance (Past 24H)

Key statistics

Cassava Sciences Inc vs Peloton Interactive Inc — how do they compare? Cassava Sciences Inc trades at $1.06 (market cap $53.14M), while Peloton Interactive Inc trades at $6.32 (market cap $2.74B). The key difference: Peloton Interactive Inc is far larger — about 51.6× Cassava Sciences Inc's market cap, and Peloton Interactive Inc is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.

FLNAPTON
Market Cap
$53.14M$2.74B
Sector
HealthConsumer Cyclical
52-Week High
$4.64$9.00
52-Week Low
$1.09$3.71
Enterprise Value
-$33.43M$3.34B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cassava Sciences Inc

FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.

Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.

Peloton Interactive Inc

Peloton (PTON) trades at $6.39, up 3.73% today, with a bullish technical signal from moving averages but overbought RSI readings. The company shows improving fundamentals, with operating cash flow turning positive at $333 million in 2025 and net losses narrowing to -$119 million. Recent news highlights stabilization efforts, including a new CFO appointment and inclusion in the S&P SmallCap 600 index, though revenue declines persist.

The outlook remains cautious; while cost cuts drive profitability improvements, sustained revenue growth is elusive. Analyst consensus is a Buy with a $7.50 target, but high debt and negative equity pose significant risks. The stock's near-term performance hinges on execution of the turnaround strategy amid competitive pressures.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA

About Peloton Interactive Inc

Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product revenue consists of sales of bike and tread and related accessories, associated fees for delivery and installation, and extended warranty agreements. Subscription revenue consists of revenue generated from monthly Connected Fitness Subscription and Digital Subscription. The company generates the majority of the revenue from the sale of Connected Fitness Products.

Read more on PTON